Upper Airway Stimulation Therapy

Upper Airway Stimulation Therapy

Upper Airway Stimulation Therapy

On this page

UAS Fundamentals - Nerve Zapper Intro

  • Upper Airway Stimulation (UAS): Implantable neurostimulation device for treating Obstructive Sleep Apnea (OSA).
  • Indication: For moderate to severe OSA patients who are intolerant or non-adherent to CPAP therapy.
  • Mechanism: Delivers mild electrical stimulation to the hypoglossal nerve (CN XII) during sleep.
    • Stimulation is synchronized with the patient's breathing.
    • Prevents airway collapse, especially at the tongue base.
  • Components:
    • Implantable pulse generator (IPG) - usually placed in the chest.
    • Sensing lead - detects respiratory effort.
    • Stimulation lead - activates genioglossus muscle for tongue movement.
  • Goal: Improve airway patency by stiffening and protruding the tongue.

    ⭐ UAS primarily targets the genioglossus muscle via hypoglossal nerve stimulation.

  • "Nerve Zapper": Colloquial term describing its electrical action on the nerve.

Upper Airway Stimulation Device Placement

Patient Selection - The "Who's Who"

Key to successful Upper Airway Stimulation (UAS) is meticulous patient selection.

  • Inclusion Criteria:
    • Age: ≥18 years
    • Moderate to Severe OSA: AHI 15-65/hr, predominantly obstructive
    • BMI: <32-35 kg/m² (device-specific, e.g., Inspire uses <32)
    • CPAP failure or intolerance (documented)
    • Patient motivation & realistic expectations
  • Exclusion Criteria (Key):
    • Anatomical:
      • Complete Concentric Collapse (CCC) of soft palate on DISE
    • Physiological:
      • Significant central sleep apnea (>25% of events)
      • Hypoventilation syndromes
    • BMI > 32-35 kg/m²
    • Certain neuromuscular diseases

⭐ Drug-Induced Sleep Endoscopy (DISE) is mandatory to exclude complete concentric collapse (CCC) at the velopharynx, a key contraindication.

The Device & Procedure - Implant Insights

  • UAS System Components:
    • Implantable Pulse Generator (IPG): Placed in a subcutaneous chest wall pocket.
    • Stimulation Lead: Cuff electrode on hypoglossal nerve (HGN XII), specifically targeting branches innervating the genioglossus muscle (tongue protrusor).
    • Respiratory Sensing Lead: Placed between intercostal muscles; detects respiratory effort to synchronize stimulation.
  • Surgical Implantation:
    • Procedure performed under general anesthesia.
    • Typically involves two to three incisions: submandibular (for HGN lead), infraclavicular (for IPG), and lateral thoracic (for sensing lead).
    • Intraoperative nerve integrity monitoring is essential.
  • Activation & Titration:
    • Device typically activated ~1 month post-operatively to allow for healing.
    • Optimal stimulation settings are determined via a titration study in a sleep laboratory.

⭐ The UAS system consists of three main components: a stimulation electrode cuff on the hypoglossal nerve, a respiratory sensing lead, and an implantable pulse generator (IPG). Upper Airway Stimulation System Placement

Outcomes & Hurdles - Zapping Success?

  • Positive Outcomes:
    • ↓ AHI (Apnea-Hypopnea Index).
    • ↓ ODI (Oxygen Desaturation Index).
    • ↓ ESS (Epworth Sleepiness Scale) scores.
    • ↑ QoL (Quality of Life).
    • Snoring reduction.
    • Sustained long-term efficacy in responders.
  • Defining Success:

    ⭐ Successful UAS therapy is often defined by a >50% reduction in AHI to <20/hr and significant improvement in ODI and subjective sleepiness (ESS).

  • Potential Hurdles & Complications:
    • Strict patient selection: BMI <32-35 kg/m², AHI 15-65/hr, specific collapse patterns (no CCC at velum).
    • Surgical risks: Hypoglossal nerve (CN XII) injury (transient/rare), infection, pain.
    • Device-related: Discomfort, lead issues (fracture/migration), battery depletion.
    • Titration period post-implantation.
    • Cost.
    • Tongue stimulation awareness.

High‑Yield Points - ⚡ Biggest Takeaways

  • UAS treats OSA via hypoglossal nerve (CN XII) stimulation, improving airway patency.
  • Synchronous tongue protrusion with inspiration relieves retrolingual obstruction.
  • For moderate-severe OSA (AHI 15-65), BMI <32-35 kg/m², with CPAP failure/intolerance.
  • DISE is essential to exclude Complete Concentric Collapse (CCC) at the palate.
  • Significantly reduces AHI and Oxygen Desaturation Index (ODI), improving sleep quality.
  • Implantable system: pulse generator, sensing lead (intercostal), and CN XII stimulation cuff_._

Practice Questions: Upper Airway Stimulation Therapy

Test your understanding with these related questions

Transection at mid-pons level with intact vagus results in:

1 of 5

Flashcards: Upper Airway Stimulation Therapy

1/3

Stimulation of the _____ nerve can be used as a therapy for obstructive sleep apnea by increasing the diameter of the oropharyngeal airway

TAP TO REVEAL ANSWER

Stimulation of the _____ nerve can be used as a therapy for obstructive sleep apnea by increasing the diameter of the oropharyngeal airway

hypoglossal

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial